Precise nanomedicine for intelligent therapy of cancer

H Chen, Z Gu, H An, C Chen, J Chen, R Cui… - Science China …, 2018 - Springer
Precise nanomedicine has been extensively explored for efficient cancer imaging and
targeted cancer therapy, as evidenced by a few breakthroughs in their preclinical and …

Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications

CD Spicer, C Jumeaux, B Gupta… - Chemical Society …, 2018 - pubs.rsc.org
Peptide–and protein–nanoparticle conjugates have emerged as powerful tools for
biomedical applications, enabling the treatment, diagnosis, and prevention of disease. In …

Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects

S Kunjachan, J Ehling, G Storm, F Kiessling… - Chemical …, 2015 - ACS Publications
Nanomedicine is defined as “the application of nanotechnology to medicine, including the
use of nanometer-sized carrier materials for facilitating disease diagnosis, disease treatment …

Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy

L Zhu, Z Zhou, H Mao, L Yang - Nanomedicine, 2017 - Taylor & Francis
Recent advances in the development of magnetic nanoparticles (MNPs) have shown
promise in the development of new personalized therapeutic approaches for clinical …

Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?

W Jeong, J Bu, LJ Kubiatowicz, SS Chen, YS Kim… - Nano …, 2018 - Springer
Peptide–nanoparticle conjugates (PNCs) have recently emerged as a versatile tool for
biomedical applications. Synergism between the two promising classes of materials allows …

Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review

S Indoria, V Singh, MF Hsieh - International journal of pharmaceutics, 2020 - Elsevier
Nanotheranostics is fast-growing pharmaceutical technology for simultaneously monitoring
drug release and its distribution, and to evaluate the real time therapeutic efficacy through a …

[HTML][HTML] Pretargeting in nuclear imaging and radionuclide therapy: Improving efficacy of theranostics and nanomedicines

EJL Stéen, PE Edem, K Nørregaard, JT Jørgensen… - Biomaterials, 2018 - Elsevier
Pretargeted nuclear imaging and radiotherapy have recently attracted increasing attention
for diagnosis and treatment of cancer with nanomedicines. This is because it conceptually …

Functional status of xylem through time

CR Brodersen, AB Roddy, JW Wason… - Annual Review of …, 2019 - annualreviews.org
Water transport in vascular plants represents a critical component of terrestrial water cycles
and supplies the water needed for the exchange of CO2 in the atmosphere for …

[HTML][HTML] Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications

K Živojević, M Mladenović, M Djisalov… - Journal of Controlled …, 2021 - Elsevier
Targeted nanomaterials for cancer theranostics have been the subject of an expanding
volume of research studies in recent years. Mesoporous silica nanoparticles (MSNs) are …

Advanced methods for radiolabeling multimodality nanomedicines for SPECT/MRI and PET/MRI

J Lamb, JP Holland - Journal of Nuclear Medicine, 2018 - Soc Nuclear Med
The advent of hybrid cameras that combine MRI with either SPECT or PET has stimulated
growing interest in develo** multimodality imaging probes. Countless options are …